Revenue
0 USD
2025 Q3 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Market value is not computed: no recent price is available.
Annual consolidated revenue for 2024: about USD 31.08K, using the latest reported figures. The previous period, 2023, was about USD 9.561K.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-17; this is not a statement that none were filed.
These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.
| Measure | Period | Value |
|---|---|---|
| Net income | 2020-06-12 – 2020-06-30 | -760 USD Source Dispute |
| Operating cash flow | 2020-06-12 – 2020-06-30 | 740 USD Source Dispute |
| Operating expenses | 2020-06-12 – 2020-06-30 | -760 USD Source Dispute |
| Operating income | 2020-06-12 – 2020-06-30 | -760 USD Source Dispute |
| Revenue | 2020-06-12 – 2020-06-30 | 0 USD Source Dispute |
5392 USD
6450000 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
7.55 thousand USD
2024-04-01 – 2025-03-31
-8.75 thousand USD
2024-04-01 – 2025-03-31
9.52 thousand USD
2024-04-01 – 2025-03-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-01-30.
Financial data available through: 2024-06-30.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 9,561
–
Current period
USD 31,079
–
31079 − 9561 = 21518 USD
9561 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source31079 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 8,827
–
Current period
−USD 11,682
–
-11682 − -8827 = -2855 USD
-8827 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source-11682 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 4,163
–
Current period
USD 7,898
–
7898 − -4163 = 12061 USD
-4163 USD · 2022-07-01 – 2023-06-30
Inspect prior input Prior source7898 USD · 2023-07-01 – 2024-06-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2020-07-01 – 2021-06-30 | 4970 | 12530 Derived | -7560 | 0 Derived | -7560 | Unavailable | Source
|
| 2022 2021-07-01 – 2022-06-30 | 5000 | 19887 Derived | -14887 | 0 Derived | -14887 | Unavailable | Source
|
| 2023 2022-07-01 – 2023-06-30 | 9561 | 18388 Derived | -8827 | 0 Derived | -8827 | Unavailable | Source
|
| 2024 2023-07-01 – 2024-06-30 | 31079 | 42761 Derived | -11682 | 0 Derived | -11682 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 4970 |
|
| 2022 | Revenue | 5000 |
|
| 2023 | Revenue | 9561 |
|
| 2024 | Revenue | 31079 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | 0.6% |
|
| 2023 | Year over year | 91.2% |
|
| 2024 | Year over year | 225.1% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | -152.1% |
|
| 2022 | Operating margin | -297.7% |
|
| 2023 | Operating margin | -92.3% |
|
| 2024 | Operating margin | -37.6% |
|
| 2021 | Net margin | -152.1% |
|
| 2022 | Net margin | -297.7% |
|
| 2023 | Net margin | -92.3% |
|
| 2024 | Net margin | -37.6% |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -3810 |
|
| 2022 | Operating cash flow | -20689 |
|
| 2023 | Operating cash flow | -4163 |
|
| 2024 | Operating cash flow | 7898 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 58.9% |
|
| 2022 | Liabilities / assets | 40.4% |
|
| 2023 | Liabilities / assets | 78.8% |
|
| 2024 | Liabilities / assets | 143.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | Not reported |
|
| 2022 | Current assets / current liabilities | Not reported |
|
| 2023 | Current assets / current liabilities | Not reported |
|
| 2024 | Current assets / current liabilities | 0.08× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2020-07-01 – 2021-06-30 | −USD 7,560 Exact valueExact value: -7560 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3,810 Exact valueExact value: -3810 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-07-01 – 2022-06-30 | −USD 14,887 Exact valueExact value: -14887 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20,689 Exact valueExact value: -20689 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-07-01 – 2023-06-30 | −USD 8,827 Exact valueExact value: -8827 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4,163 Exact valueExact value: -4163 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-07-01 – 2024-06-30 | −USD 11,682 Exact valueExact value: -11682 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 7,898 Exact valueExact value: 7898 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
18 filings · 766 latest values · 766 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001818550, 1818550, ICDX, edgar:1818550
Also known as INCORDEX CORP., Incordex Corp.